Floatz logo

241 assets in Parkinson Disease

Therapeutic assets addressing Parkinson Disease, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
nm-101
Parkinson Disease
Neuramedy Co. Ltd.P1C (37)
Stem-Pd
Parkinson Disease
Region SkaneP1C (37)
Tenofovir Disoproxil Fumarate
Parkinson Disease
The Fourth Affiliated Hospital of Zhejiang University School of MedicineP1C (37)
C11-SY08
Parkinson Disease
Massachusetts General HospitalEarly P1C (36)
[18F]MODAG-009
Parkinson Disease
MODAG GmbHEarly P1C (34)
NOS
Parkinson Disease
University of PennsylvaniaEarly P1C (34)
Yohimbine
Parkinson Disease
Hospices Civils de LyonEarly P1C (34)
Apsolol
Parkinson Disease
Multan Medical And Dental CollegeN/AD (30)
Bioactivated Gra For Adult Patients
Parkinson Disease
IRCCS Centro Neurolesi Bonino PulejoN/AD (30)
Jnj-54135419
Parkinson Disease
RenJi HospitalN/AD (30)
mk-6240
Parkinson Disease
Universitaire Ziekenhuizen KU LeuvenN/AD (30)
Ramifentanyl
Parkinson Disease
RenJi HospitalN/AD (30)
SDM-8
Parkinson Disease
Universitaire Ziekenhuizen KU LeuvenN/AD (30)
Vildagliptin
Parkinson Disease
First Affiliated Hospital, Sun Yat-Sen UniversityN/AD (30)
Apigenine
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
Carfentanyl
Parkinson Disease
Hospices Civils de LyonN/AD (28)
Chamomile
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
Clostridium Butyricum Miyairi 588
Parkinson Disease
Kaohsiung Medical University Chung-Ho Memorial HospitalN/AD (28)
Glucose, Anhydrous
Parkinson Disease
University Hospital Schleswig-HolsteinN/AD (28)
Lecanemab
Parkinson Disease
Yonsei UniversityN/AD (28)
Lidocaine
Parkinson Disease
Babujinaya CelaN/AD (28)
Ropivacaine
Parkinson Disease
Changhai HospitalN/AD (28)
Saffron
Parkinson Disease
Jinnah Postgraduate Medical CentreN/AD (28)
alc01 therapy
Parkinson Disease
iCamuno Biotherapeutics Ltd.P1NR ()
DHE
Parkinson Disease
Second Affiliated Hospital of Soochow UniversityP4NR ()
Energi-F705 Tablets
Parkinson Disease
Energenesis Biomedical Co., Ltd.P2NR ()
ica07 therapy
Parkinson Disease
iCamuno Biotherapeutics Ltd.P1NR ()
kl002
Parkinson Disease
Second Affiliated Hospital, School of Medicine, Zhejiang UniversityEarly P1NR ()
ly03017
Parkinson Disease
Luye Pharma Group Ltd.P1NR ()
Nouvneu001
Parkinson Disease
iRegene Therapeutics Co., Ltd.P1NR ()
Ondansetron
Parkinson Disease
University College, LondonP2NR ()
Rotigexole
Parkinson Disease
Eva PharmaN/ANR ()
Showing 201 to 241 of 241 assets
PreviousPage 5 of 5Next